Published in PLoS One on March 02, 2010
Advances in human B19 erythrovirus biology. J Virol (2010) 1.10
Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells. J Virol (2010) 1.00
Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα. PLoS Pathog (2011) 0.99
Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients. PLoS One (2012) 0.85
Overexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromes. PLoS One (2013) 0.85
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
Characterization of the transcriptome profiles related to globin gene switching during in vitro erythroid maturation. BMC Genomics (2012) 0.82
Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression. PLoS One (2012) 0.81
Characterization of the early steps of human parvovirus B19 infection. J Virol (2012) 0.81
Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol (2015) 0.78
Formaldehyde induces micronuclei in mouse erythropoietic cells and suppresses the expansion of human erythroid progenitor cells. Toxicol Lett (2013) 0.77
Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells. PLoS One (2016) 0.77
The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells. Viruses (2016) 0.75
α-Hemoglobin-stabilizing protein is a sensitive and specific marker of erythroid precursors. Am J Surg Pathol (2012) 0.75
Parvovirus B19. N Engl J Med (2004) 6.83
CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest (2001) 5.72
Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science (1993) 4.12
Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol (2004) 3.76
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02
Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A (2006) 2.51
Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro. J Exp Med (1978) 2.33
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol (1999) 1.97
Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood (1996) 1.93
Proliferation and maturation of human erythroid progenitors in liquid culture. Blood (1989) 1.78
Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood (1987) 1.75
Clinical aspects of parvovirus B19 infection. J Intern Med (2006) 1.70
In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis (2002) 1.70
Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol (1988) 1.62
Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication. J Virol (2007) 1.40
Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol (1989) 1.37
Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis (1995) 1.37
Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis (1995) 1.31
Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood (1990) 1.29
Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br J Haematol (1999) 1.27
Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome. J Virol (2008) 1.26
Changes in cell surface antigen expressions during proliferation and differentiation of human erythroid progenitors. Blood (1992) 1.24
First continuous propagation of B19 parvovirus in a cell line. Blood (1992) 1.22
Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol (1999) 1.15
Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol (2004) 1.13
Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection. J Clin Microbiol (1999) 1.09
Human erythroid burst-forming units. Growth in vitro is dependent on monocytes, but not T lymphocytes. J Clin Invest (1981) 1.07
Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers. Leuk Lymphoma (1994) 1.06
T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19. J Infect Dis (2001) 1.03
Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity. J Virol Methods (1999) 1.01
In vitro expansion of human peripheral blood CD34+ cells. Blood (1993) 0.98
Different patterns of restriction to B19 parvovirus replication in human blast cell lines. Virology (2000) 0.95
Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: role of insulinlike growth factor 1. Blood (1991) 0.94
Parvovirus B19 replication in human umbilical cord blood cells. Virology (1992) 0.91
Expression of major blood group antigens on human erythroid cells in a two phase liquid culture system. Blood (1990) 0.90
Prospective identification of erythroid elements in cultured peripheral blood. Exp Hematol (1999) 0.89
In vitro propagation of parvovirus B19 in primary foetal liver culture. J Gen Virol (1991) 0.89
T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19. Vaccine (2004) 0.88
Developmental regulation of erythropoiesis by hematopoietic growth factors: analysis on populations of BFU-E from bone marrow, peripheral blood, and fetal liver. Blood (1989) 0.88
Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood. J Virol (1992) 0.88
Diagnosis of human parvovirus B19 infections by detection of epitope-type-specific VP2 IgG. J Med Virol (2001) 0.87
Circulating CD14-CD36+ peripheral blood mononuclear cells constitutively produce interleukin-10. J Leukoc Biol (2007) 0.85
Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization. Br J Haematol (1991) 0.84
Deficiency of cyclooxygenases transcripts in cultured primary bronchial epithelial cells of aspirin-sensitive asthmatics. J Physiol Pharmacol (2007) 0.84
Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage. J Leukoc Biol (2007) 0.83
Inactivation of parvovirus B19 in coagulation factor concentrates by UVC radiation: assessment by an in vitro infectivity assay using CFU-E derived from peripheral blood CD34+ cells. Transfusion (2001) 0.82
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit. Virology (2006) 0.82
Functional analysis and quantitative determination of the expression profile of human parvovirus B19. Virology (2008) 0.80
The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial. Stem Cells (2003) 0.79
Ex-vivo expansion of CFU-GM and BFU-E in unselected PBMC cultures with Flt3L is enhanced by autologous plasma. Cytotherapy (1999) 0.76
The perfect ocean for drought. Science (2003) 4.84
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med (2005) 4.60
Serodiagnosis of human bocavirus infection. Clin Infect Dis (2008) 2.72
Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A (2006) 2.51
Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B. Am J Gastroenterol (2007) 2.25
IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes. Proc Natl Acad Sci U S A (2002) 1.96
Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland. Emerg Infect Dis (2009) 1.87
Serologically verified human bocavirus pneumonia in children. Pediatr Pulmonol (2010) 1.85
Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis (2002) 1.81
Human bocavirus-the first 5 years. Rev Med Virol (2011) 1.81
Technique for retrieval of J-tip guide wire without withdrawing introducer needle during central venous cannulation by seldinger technique. Anesth Analg (2004) 1.70
Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland. Emerg Infect Dis (2012) 1.67
Infections preceding early arthritis in southern Sweden: a prospective population-based study. J Rheumatol (2003) 1.59
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol (2008) 1.50
Establishment of a reverse genetics system for studying human bocavirus in human airway epithelia. PLoS Pathog (2012) 1.43
Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J Virol (2010) 1.42
Interactome map uncovers phosphatidylserine transport by oxysterol-binding proteins. Nature (2013) 1.42
Survival benefit from early revascularization in elderly patients with cardiogenic shock after acute myocardial infarction: a cohort study. J Invasive Cardiol (2009) 1.41
A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Immunol (2007) 1.41
A new parvovirus genotype persistent in human skin. Virology (2002) 1.40
Early anticoagulation after mechanical valve implantation, and related complications. J Heart Valve Dis (2008) 1.39
Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections. J Virol (2008) 1.39
Periprosthetic fractures of the femur after total knee arthroplasty. J Orthop Traumatol (2010) 1.37
Seroepidemiology of human bocaviruses 1-4. J Infect Dis (2011) 1.37
Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol (2010) 1.34
Exercise for reducing fear of falling in older people living in the community. Cochrane Database Syst Rev (2014) 1.33
Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma. BMC Cancer (2008) 1.32
Dating of human bocavirus infection with protein-denaturing IgG-avidity assays-Secondary immune activations are ubiquitous in immunocompetent adults. J Clin Virol (2010) 1.32
Mutation analysis of the KIF21A gene in an Indian family with CFEOM1: implication of CpG methylation for most frequent mutations. Ophthalmic Genet (2004) 1.32
An RNA isolation system for plant tissues rich in secondary metabolites. BMC Res Notes (2011) 1.32
Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma. J Exp Med (2003) 1.29
Seroepidemiology of the newly found trichodysplasia spinulosa-associated polyomavirus. J Infect Dis (2011) 1.28
Severe human bocavirus infection, Germany. Emerg Infect Dis (2011) 1.27
Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity. Proc Natl Acad Sci U S A (2012) 1.26
Do nursing homes for older people have the support they need to provide end-of-life care? A mixed methods enquiry in England. Palliat Med (2011) 1.25
Human bocavirus in patients with encephalitis, Sri Lanka, 2009-2010. Emerg Infect Dis (2013) 1.25
Identification of genes associated with tumorigenesis of retinoblastoma by microarray analysis. Genomics (2007) 1.24
Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris) (2002) 1.24
Cytosolic antiviral RNA recognition pathway activates caspases 1 and 3. J Immunol (2008) 1.24
Serodiagnosis of primary infections with human parvovirus 4, Finland. Emerg Infect Dis (2011) 1.22
Real-time quantitative PCR detection of four human bocaviruses. J Clin Microbiol (2010) 1.20
Human hippocampal subfields in young adults at 7.0 T: feasibility of imaging. Radiology (2010) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Detection of human bocavirus in the cerebrospinal fluid of children with encephalitis. Clin Infect Dis (2012) 1.17
Novel human bufavirus genotype 3 in children with severe diarrhea, Bhutan. Emerg Infect Dis (2014) 1.17
A comparison of standardized versus "usual" blood pressure measurements in hemodialysis patients. Am J Kidney Dis (2002) 1.17
Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanita (2004) 1.16
Life-threatening respiratory tract disease with human bocavirus-1 infection in a 4-year-old child. J Clin Microbiol (2011) 1.15
Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency. J Clin Virol (2009) 1.14
Natriuretic peptide receptor a as a novel anticancer target. Cancer Res (2008) 1.14
New molecular virus detection methods and their clinical value in lower respiratory tract infections in children. Paediatr Respir Rev (2012) 1.13
Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol (2004) 1.13
The efficacy of a herbal-based toothpaste in the control of plaque and gingivitis: a clinico-biochemical study. Indian J Dent Res (2010) 1.13
Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics. J Clin Virol (2005) 1.12
Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring. Am J Epidemiol (2016) 1.08
Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells. J Immunol (2007) 1.08
Bufavirus in feces of patients with gastroenteritis, Finland. Emerg Infect Dis (2014) 1.07
Long term transcript accumulation during the development of dehydration adaptation in Cicer arietinum. Plant Physiol (2004) 1.07
Retrograde submental intubation by pharyngeal loop technique in a patient with faciomaxillary trauma and restricted mouth opening. Anesth Analg (2005) 1.06
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Detection of deletions in de novo "balanced" chromosome rearrangements: further evidence for their role in phenotypic abnormalities. Genet Med (2004) 1.04
Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics. J Biol Chem (2012) 1.04
Assessment of dietary compliance to gluten free diet and psychosocial problems in Indian children with celiac disease. Indian J Pediatr (2010) 1.03
New respiratory viruses and the elderly. Open Respir Med J (2011) 1.02
Methane emission from fixed dome biogas plants in hilly and plain regions of northern India. Bioresour Technol (2004) 1.01
Single nucleotide polymorphisms in homocysteine metabolism pathway genes: association of CHDH A119C and MTHFR C677T with hyperhomocysteinemia. Circ Cardiovasc Genet (2009) 1.01
Assessment of self-awareness among rural adolescents: A cross-sectional study. Indian J Endocrinol Metab (2013) 1.01
Pain on injection of lipid-free propofol and propofol emulsion containing medium-chain triglyceride: a comparative study. Anesth Analg (2005) 1.00
Biological and immunological relations among human parvovirus B19 genotypes 1 to 3. J Virol (2007) 1.00
A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid. BMC Infect Dis (2004) 0.98
New respiratory viral infections. Curr Opin Pulm Med (2012) 0.97
Genomic features of the human bocaviruses. Future Virol (2012) 0.97
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology (2008) 0.96
Human circovirus TT virus genotype 6 expresses six proteins following transfection of a full-length clone. J Virol (2005) 0.96
Human bocavirus infection diagnosed serologically among children admitted to hospital with community-acquired pneumonia in a tropical region. J Med Virol (2012) 0.95